ICU Medical, Incorporated Company Profile (NASDAQ:ICUI)

About ICU Medical, Incorporated (NASDAQ:ICUI)

ICU Medical, Incorporated logoICU Medical, Inc. is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company's product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. The primary critical care products it manufactures are Hemodynamic Monitoring Systems, SafeSet Closed Blood Sampling and Conservation System, Transpac Consumable Blood Pressure Transducers and Other Critical Care Products. The primary oncology products it manufactures are ChemoLock Needlefree CSTD, ChemoClave Needlefree CSTD and Diana Hazardous Drug Compounding System. As of December 31, 2016, its products were used in acute care hospitals and ambulatory clinics in more than 65 countries throughout the world.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Symbol: NASDAQ:ICUI
  • CUSIP: 44930G10
  • Web:
  • Market Cap: $3.17 billion
  • Outstanding Shares: 19,799,000
Average Prices:
  • 50 Day Moving Avg: $155.34
  • 200 Day Moving Avg: $148.80
  • 52 Week Range: $100.27 - $175.73
  • Trailing P/E Ratio: 28.38
  • Foreward P/E Ratio: 25.83
  • P/E Growth: 3.07
Sales & Book Value:
  • Annual Revenue: $526.06 million
  • Price / Sales: 6.03
  • Book Value: $57.67 per share
  • Price / Book: 2.78
  • EBIDTA: $102.13 million
  • Net Margins: 15.18%
  • Return on Equity: 10.70%
  • Return on Assets: 9.99%
  • Current Ratio: 15.47%
  • Quick Ratio: 13.91%
  • Average Volume: 134,713 shs.
  • Beta: 0.33
  • Short Ratio: 6.17

Frequently Asked Questions for ICU Medical, Incorporated (NASDAQ:ICUI)

What is ICU Medical, Incorporated's stock symbol?

ICU Medical, Incorporated trades on the NASDAQ under the ticker symbol "ICUI."

How were ICU Medical, Incorporated's earnings last quarter?

ICU Medical, Incorporated (NASDAQ:ICUI) posted its quarterly earnings data on Wednesday, May, 10th. The company reported $1.68 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.45 by $1.23. The company earned $247.74 million during the quarter, compared to analyst estimates of $237.12 million. ICU Medical, Incorporated had a return on equity of 10.70% and a net margin of 15.18%. The firm's quarterly revenue was up 175.7% on a year-over-year basis. During the same quarter last year, the company earned $1.26 earnings per share. View ICU Medical, Incorporated's Earnings History.

What guidance has ICU Medical, Incorporated issued on next quarter's earnings?

ICU Medical, Incorporated updated its FY17 earnings guidance on Wednesday, March, 1st. The company provided EPS guidance of $3.55-$3.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.68. The company issued revenue guidance of $1.2-$1.25 billion, compared to the consensus revenue estimate of $846.93 million.

Where is ICU Medical, Incorporated's stock going? Where will ICU Medical, Incorporated's stock price be in 2017?

2 brokers have issued 1 year price objectives for ICU Medical, Incorporated's shares. Their forecasts range from $119.00 to $119.00. On average, they expect ICU Medical, Incorporated's stock price to reach $119.00 in the next year. View Analyst Ratings for ICU Medical, Incorporated.

Who are some of ICU Medical, Incorporated's key competitors?

Who owns ICU Medical, Incorporated stock?

ICU Medical, Incorporated's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (10.83%), Janus Capital Management LLC (7.81%), Vanguard Group Inc. (6.86%), Renaissance Technologies LLC (4.27%), Wellington Management Group LLP (4.00%) and Champlain Investment Partners LLC (3.04%). Company insiders that own ICU Medical, Incorporated stock include Alison D Burcar, George A Lopez, Joseph R Saucedo, Kevin J Mcgrody, Richard Md Sherman, Robert S Swinney, Scott E Lamb, Steven Riggs, Thomas D Mccall, Virginia Ruth Sanzone and Vivek Jain. View Institutional Ownership Trends for ICU Medical, Incorporated.

Who sold ICU Medical, Incorporated stock? Who is selling ICU Medical, Incorporated stock?

ICU Medical, Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Dimensional Fund Advisors LP, Bank of New York Mellon Corp, York Capital Management Global Advisors LLC, Russell Investments Group Ltd., Renaissance Technologies LLC, Monarch Partners Asset Management LLC and Thrivent Financial For Lutherans. Company insiders that have sold ICU Medical, Incorporated stock in the last year include Alison D Burcar, Joseph R Saucedo, Kevin J Mcgrody, Richard Md Sherman, Robert S Swinney, Scott E Lamb, Steven Riggs, Thomas D Mccall, Virginia Ruth Sanzone and Vivek Jain. View Insider Buying and Selling for ICU Medical, Incorporated.

Who bought ICU Medical, Incorporated stock? Who is buying ICU Medical, Incorporated stock?

ICU Medical, Incorporated's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Janus Capital Management LLC, Redmile Group LLC, Wells Fargo & Company MN, Kennedy Capital Management Inc., Wellington Management Group LLP, Goldman Sachs Group Inc. and Royce & Associates LP. View Insider Buying and Selling for ICU Medical, Incorporated.

How do I buy ICU Medical, Incorporated stock?

Shares of ICU Medical, Incorporated can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of ICU Medical, Incorporated stock cost?

One share of ICU Medical, Incorporated stock can currently be purchased for approximately $160.15.

Analyst Ratings

Consensus Ratings for ICU Medical, Incorporated (NASDAQ:ICUI) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $119.00 (25.69% downside)

Analysts' Ratings History for ICU Medical, Incorporated (NASDAQ:ICUI)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/11/2017Roth CapitalDowngradeBuy -> NeutralHighView Rating Details
8/11/2016Piper Jaffray CompaniesReiterated RatingNeutral$115.00 -> $119.00N/AView Rating Details
3/11/2016GabelliInitiated CoverageBuy$128.00N/AView Rating Details
11/3/2015Raymond James Financial, Inc.Boost Price Target$120.00 -> $128.00N/AView Rating Details
(Data available from 5/26/2015 forward)


Earnings History for ICU Medical, Incorporated (NASDAQ:ICUI)
Earnings by Quarter for ICU Medical, Incorporated (NASDAQ:ICUI)
Earnings History by Quarter for ICU Medical, Incorporated (NASDAQ:ICUI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2017Q1 2017$0.45$1.68$237.12 million$247.74 millionViewN/AView Earnings Details
3/1/2017Q4 2016$1.19$1.20$94.43 million$95.70 millionViewListenView Earnings Details
11/9/2016Q3 2016$1.17$1.35$93.04 million$97.11 millionViewListenView Earnings Details
8/8/2016Q2$1.05$1.15$89.66 million$96.70 millionViewN/AView Earnings Details
5/10/2016Q1$1.01$1.14$88.04 million$89.90 millionViewListenView Earnings Details
2/3/2016Q4$0.96$0.96$86.57 million$90.40 millionViewListenView Earnings Details
11/5/2015Q315$0.84$1.00$81.15 million$86.00 millionViewListenView Earnings Details
8/10/2015Q215$0.69$0.97$78.89 million$83.80 millionViewListenView Earnings Details
5/5/2015Q115$0.47$0.91$77.28 million$81.50 millionViewListenView Earnings Details
2/9/2015Q414$0.44$0.58$76.01 million$79.90 millionViewN/AView Earnings Details
11/10/2014Q314$0.22$0.56$73.00 million$77.50 millionViewN/AView Earnings Details
8/11/2014Q214$0.34$0.38$74.13 million$78.70 millionViewN/AView Earnings Details
5/6/2014Q114$0.34$0.28$70.79 million$73.20 millionViewN/AView Earnings Details
2/12/2014Q413$0.73$0.86$84.25 million$77.90 millionViewN/AView Earnings Details
10/21/2013Q313$0.67$0.72$82.64 million$82.82 millionViewN/AView Earnings Details
7/18/2013Q2 2013$0.66$0.48$83.43 million$78.70 millionViewN/AView Earnings Details
4/22/2013Q1 2013$0.44$0.58$74.06 million$74.30 millionViewN/AView Earnings Details
2/4/2013Q4 2012$0.78$0.82$82.69 million$82.70 millionViewN/AView Earnings Details
10/15/2012$0.69$0.82ViewN/AView Earnings Details
7/16/2012$0.60$0.63ViewN/AView Earnings Details
4/16/2012$0.49$0.53ViewN/AView Earnings Details
1/30/2012$0.62$0.70ViewN/AView Earnings Details
10/17/2011$0.57$0.65ViewN/AView Earnings Details
7/18/2011$0.56$0.67ViewN/AView Earnings Details
4/18/2011$0.47$0.57ViewN/AView Earnings Details
1/31/2011$0.53$0.72ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for ICU Medical, Incorporated (NASDAQ:ICUI)
2017 EPS Consensus Estimate: $4.31
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$1.07$1.07$1.07
Q2 20171$1.09$1.09$1.09
Q3 20171$1.10$1.10$1.10
Q4 20171$1.05$1.05$1.05
(Data provided by Zacks Investment Research)


Dividend History for ICU Medical, Incorporated (NASDAQ:ICUI)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for ICU Medical, Incorporated (NASDAQ:ICUI)
Insider Ownership Percentage: 15.90%
Institutional Ownership Percentage: 88.72%
Insider Trades by Quarter for ICU Medical, Incorporated (NASDAQ:ICUI)
Institutional Ownership by Quarter for ICU Medical, Incorporated (NASDAQ:ICUI)
Insider Trades by Quarter for ICU Medical, Incorporated (NASDAQ:ICUI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/17/2017Alison D BurcarVPSell18,290$160.72$2,939,568.80View SEC Filing  
5/17/2017Robert S SwinneyDirectorSell594$160.92$95,586.48View SEC Filing  
5/16/2017Joseph R SaucedoDirectorSell4,500$162.51$731,295.00View SEC Filing  
3/15/2017George A LopezDirectorBuy12,000$155.60$1,867,200.00View SEC Filing  
3/14/2017Richard Md ShermanDirectorSell3,000$152.20$456,600.00View SEC Filing  
3/13/2017Robert S SwinneyDirectorSell646$155.09$100,188.14View SEC Filing  
3/10/2017Robert S SwinneyDirectorSell1,235$151.23$186,769.05View SEC Filing  
3/10/2017Vivek JainChairmanSell22,143$150.00$3,321,450.00View SEC Filing  
3/8/2017Joseph R SaucedoDirectorSell1,500$149.56$224,340.00View SEC Filing  
3/6/2017Virginia Ruth SanzoneVPSell681$148.38$101,046.78View SEC Filing  
3/6/2017Vivek JainChairmanSell589$150.00$88,350.00View SEC Filing  
2/24/2017Steven RiggsVPSell31,250$151.99$4,749,687.50View SEC Filing  
11/14/2016Robert S SwinneyDirectorSell2,025$142.88$289,332.00View SEC Filing  
10/6/2016Richard Md ShermanDirectorSell1,500$140.60$210,900.00View SEC Filing  
9/19/2016Richard Md ShermanDirectorSell3,000$122.51$367,530.00View SEC Filing  
9/13/2016Scott E LambCFOSell1,474$121.61$179,253.14View SEC Filing  
9/13/2016Steven RiggsVPSell44,739$121.78$5,448,315.42View SEC Filing  
9/12/2016Scott E LambCFOSell28,526$121.78$3,473,896.28View SEC Filing  
9/12/2016Virginia Ruth SanzoneVPSell1,903$121.29$230,814.87View SEC Filing  
8/24/2016Vivek JainChairmanSell7,268$124.25$903,049.00View SEC Filing  
8/15/2016Kevin J McgrodyInsiderSell14,257$124.11$1,769,436.27View SEC Filing  
8/12/2016Thomas D MccallVPSell18,559$124.24$2,305,770.16View SEC Filing  
8/11/2016Thomas D MccallVPSell2,071$126.07$261,090.97View SEC Filing  
8/9/2016Joseph R SaucedoDirectorSell8,000$125.00$1,000,000.00View SEC Filing  
7/29/2016Joseph R SaucedoDirectorSell2,000$115.47$230,940.00View SEC Filing  
6/29/2016Steven RiggsVPSell20,000$110.00$2,200,000.00View SEC Filing  
5/10/2016Joseph R SaucedoDirectorSell1,875$105.00$196,875.00View SEC Filing  
5/9/2016Robert S SwinneyDirectorSell1,875$101.40$190,125.00View SEC Filing  
4/15/2016Joseph R SaucedoDirectorSell1,875$103.22$193,537.50View SEC Filing  
4/11/2016Robert S SwinneyDirectorSell1,875$101.35$190,031.25View SEC Filing  
3/31/2016Scott E LambTreasurerSell44,026$105.00$4,622,730.00View SEC Filing  
3/31/2016Steven RiggsVPSell20,000$105.00$2,100,000.00View SEC Filing  
3/21/2016Steven RiggsVPSell20,000$100.00$2,000,000.00View SEC Filing  
2/4/2016Scott E. LambTreasurerSell974$105.00$102,270.00View SEC Filing  
1/4/2016Steven RiggsVPSell17,532$107.27$1,880,657.64View SEC Filing  
12/11/2015George A. LopezDirectorSell4,168$108.25$451,186.00View SEC Filing  
12/10/2015George A. LopezDirectorSell10,291$109.29$1,124,703.39View SEC Filing  
12/9/2015George A. LopezDirectorSell12,622$110.43$1,393,847.46View SEC Filing  
12/8/2015George A. LopezDirectorSell9,119$112.04$1,021,692.76View SEC Filing  
12/7/2015George A. LopezDirectorSell8,800$112.99$994,312.00View SEC Filing  
11/25/2015Robert S SwinneyDirectorSell3,000$112.00$336,000.00View SEC Filing  
11/3/2015George A. LopezDirectorSell20,900$111.41$2,328,469.00View SEC Filing  
11/2/2015George A. LopezDirectorSell19,100$110.69$2,114,179.00View SEC Filing  
10/6/2015George A. LopezDirectorSell10,000$106.17$1,061,700.00View SEC Filing  
10/5/2015Joseph R. SaucedoDirectorSell1,875$107.72$201,975.00View SEC Filing  
9/2/2015George A. LopezDirectorSell10,000$110.86$1,108,600.00View SEC Filing  
9/1/2015George A. LopezDirectorSell10,000$110.78$1,107,800.00View SEC Filing  
8/31/2015George A. LopezDirectorSell10,000$113.53$1,135,300.00View SEC Filing  
7/6/2015Steven RiggsVPSell33,890$97.00$3,287,330.00View SEC Filing  
6/22/2015Steven RiggsVPSell1,110$97.00$107,670.00View SEC Filing  
6/19/2015Alison D BurcarVPSell9,411$97.00$912,867.00View SEC Filing  
6/11/2015George A LopezDirectorSell16,601$96.11$1,595,522.11View SEC Filing  
6/10/2015Alison D BurcarVPSell589$97.00$57,133.00View SEC Filing  
6/10/2015George A LopezDirectorSell20,000$96.20$1,924,000.00View SEC Filing  
6/9/2015George A LopezDirectorSell12,400$94.83$1,175,892.00View SEC Filing  
6/8/2015George A LopezDirectorSell10,000$96.24$962,400.00View SEC Filing  
6/5/2015George A LopezDirectorSell10,700$95.97$1,026,879.00View SEC Filing  
6/4/2015George A LopezDirectorSell6,999$96.75$677,153.25View SEC Filing  
6/3/2015George A LopezDirectorSell11,300$97.97$1,107,061.00View SEC Filing  
6/2/2015George A LopezDirectorSell12,000$97.51$1,170,120.00View SEC Filing  
4/6/2015Joseph R SaucedoDirectorSell1,875$93.50$175,312.50View SEC Filing  
4/1/2015Richard Md ShermanDirectorSell3,000$95.00$285,000.00View SEC Filing  
3/30/2015George A LopezDirectorSell10,000$91.68$916,800.00View SEC Filing  
3/12/2015Robert S SwinneyDirectorSell3,094$90.92$281,306.48View SEC Filing  
3/4/2015George A LopezDirectorSell3,668$87.05$319,299.40View SEC Filing  
3/3/2015George A LopezDirectorSell11,432$88.15$1,007,730.80View SEC Filing  
3/2/2015George A LopezDirectorSell14,900$89.27$1,330,123.00View SEC Filing  
2/17/2015Jack BrownDirectorSell4,000$88.34$353,360.00View SEC Filing  
2/13/2015John J ConnorsDirectorSell10,000$88.31$883,100.00View SEC Filing  
2/5/2015Joseph R SaucedoDirectorSell1,875$83.53$156,618.75View SEC Filing  
2/2/2015George A LopezDirectorSell30,000$83.25$2,497,500.00View SEC Filing  
1/13/2015Richard Md ShermanDirectorSell8,500$85.00$722,500.00View SEC Filing  
1/6/2015George A LopezDirectorSell13,600$80.90$1,100,240.00View SEC Filing  
1/5/2015George A LopezDirectorSell16,400$80.75$1,324,300.00View SEC Filing  
12/22/2014Richard Md ShermanDirectorSell3,750$83.06$311,475.00View SEC Filing  
12/2/2014Alison D BurcarInsiderSell21,732$84.65$1,839,613.80View SEC Filing  
11/21/2014Scott E LambTreasurerSell17,948$80.75$1,449,301.00View SEC Filing  
11/21/2014Steven RiggsVPSell15,373$80.82$1,242,445.86View SEC Filing  
11/20/2014Scott E LambTreasurerSell45,881$81.32$3,731,042.92View SEC Filing  
11/20/2014Steven RiggsVPSell26,938$81.36$2,191,675.68View SEC Filing  
11/19/2014Scott E LambTreasurerSell18,353$83.06$1,524,400.18View SEC Filing  
11/19/2014Steven RiggsCEOSell21,732$83.11$1,806,146.52View SEC Filing  
11/10/2014George A LopezDirectorSell25,000$71.16$1,779,000.00View SEC Filing  
11/3/2014George A LopezDirectorSell25,000$70.38$1,759,500.00View SEC Filing  
9/5/2014Joseph R SaucedoDirectorSell1,875$61.39$115,106.25View SEC Filing  
8/15/2014Robert S SwinneyDirectorSell1,475$62.70$92,482.50View SEC Filing  
8/12/2014George A LopezDirectorSell12,250$62.57$766,482.50View SEC Filing  
8/11/2014George A LopezDirectorSell12,750$57.85$737,587.50View SEC Filing  
8/6/2014George A LopezDirectorSell4,300$57.77$248,411.00View SEC Filing  
8/4/2014George A LopezDirectorSell10,700$57.19$611,933.00View SEC Filing  
6/13/2014Jack BrownDirectorSell3,000$59.83$179,490.00View SEC Filing  
5/13/2014George LopezDirectorSell2,000$59.67$119,340.00View SEC Filing  
5/12/2014George LopezDirectorSell23,000$60.42$1,389,660.00View SEC Filing  
5/6/2014George LopezDirectorSell3,900$55.01$214,539.00View SEC Filing  
5/5/2014George LopezDirectorSell21,100$54.57$1,151,427.00View SEC Filing  
4/8/2014George LopezDirectorSell13,100$59.40$778,140.00View SEC Filing  
4/7/2014George LopezDirectorSell11,900$59.29$705,551.00View SEC Filing  
4/1/2014George LopezDirectorSell10,000$60.41$604,100.00View SEC Filing  
3/31/2014George LopezDirectorSell15,000$59.83$897,450.00View SEC Filing  
3/25/2014George LopezDirectorSell6,696$59.13$395,934.48View SEC Filing  
3/24/2014George LopezDirectorSell18,304$59.20$1,083,596.80View SEC Filing  
3/18/2014George LopezDirectorSell6,600$58.83$388,278.00View SEC Filing  
3/17/2014George LopezDirectorSell18,400$58.53$1,076,952.00View SEC Filing  
3/7/2014Jack BrownDirectorSell2,000$59.78$119,560.00View SEC Filing  
3/5/2014Joseph SaucedoDirectorSell3,750$60.22$225,825.00View SEC Filing  
3/5/2014Vivek JainCEOBuy30,000$58.75$1,762,500.00View SEC Filing  
2/26/2014Robert SwinneyDirectorSell4,000$58.51$234,040.00View SEC Filing  
2/25/2014Richard CostelloVPSell29,508$58.62$1,729,758.96View SEC Filing  
12/24/2013Steven RiggsCEOSell7,000$65.00$455,000.00View SEC Filing  
12/23/2013Steven RiggsCEOSell9,089$64.07$582,332.23View SEC Filing  
12/18/2013Richard Md ShermanDirectorSell3,750$65.00$243,750.00View SEC Filing  
12/11/2013George LopezDirectorSell25,000$64.27$1,606,750.00View SEC Filing  
12/10/2013George LopezDirectorSell17,100$65.36$1,117,656.00View SEC Filing  
12/9/2013George LopezDirectorSell7,900$65.95$521,005.00View SEC Filing  
11/20/2013Burcar Alison BrummettVPSell15,500$63.05$977,275.00View SEC Filing  
11/19/2013George LopezDirectorSell15,000$61.11$916,650.00View SEC Filing  
11/18/2013George LopezDirectorSell15,000$62.06$930,900.00View SEC Filing  
11/14/2013Burcar Alison BrummettVPSell10,000$62.26$622,600.00View SEC Filing  
11/12/2013George LopezDirectorSell20,000$61.64$1,232,800.00View SEC Filing  
11/5/2013Joseph R SaucedoDirectorSell1,875$60.66$113,737.50View SEC Filing  
11/1/2013Richard A CostelloVPSell20,538$61.00$1,252,818.00View SEC Filing  
10/28/2013Michael T KovalchikDirectorSell1,875$63.01$118,143.75View SEC Filing  
10/25/2013John J ConnorsDirectorSell16,875$65.15$1,099,406.25View SEC Filing  
10/25/2013Richard A CostelloVPSell12,187$63.16$769,730.92View SEC Filing  
10/24/2013Richard A CostelloVPSell63,750$64.02$4,081,275.00View SEC Filing  
10/9/2012George A LopezMajor ShareholderSell7,200$61.03$439,416.00View SEC Filing  
10/8/2012George A LopezMajor ShareholderSell17,800$61.53$1,095,234.00View SEC Filing  
8/10/2012Michael T KovalchikDirectorSell6,250$55.00$343,750.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for ICU Medical, Incorporated (NASDAQ:ICUI)
Latest Headlines for ICU Medical, Incorporated (NASDAQ:ICUI)
DateHeadline logo$321.44 Million in Sales Expected for ICU Medical, Incorporated (ICUI) This Quarter - May 26 at 4:04 PM logoRobert S. Swinney Sells 594 Shares of ICU Medical, Incorporated (ICUI) Stock - May 18 at 4:35 PM logoICU Medical, Incorporated (ICUI) VP Alison D. Burcar Sells 18,290 Shares - May 18 at 4:34 PM logoJoseph R. Saucedo Sells 4,500 Shares of ICU Medical, Incorporated (ICUI) Stock - May 16 at 10:16 PM logoEdited Transcript of ICUI earnings conference call or presentation 10-May-17 8:30pm GMT - May 16 at 5:45 PM logoICU Medical Inc. (ICUI) Climbed To A New High Following Q1 Report - May 12 at 11:32 PM logoICU Medical's (ICUI) CEO Vivek Jain on Q1 2017 Results - Earnings Call Transcript - May 11 at 11:27 PM logoICU Medical Inc. (ICUI) Has Climbed To A New High Following Q1 Report - May 11 at 11:27 PM logoICU Medical, Incorporated (ICUI) Downgraded to "Neutral" at Roth Capital - May 11 at 2:29 PM logoICU Medical, Incorporated (ICUI) Releases Quarterly Earnings Results, Beats Expectations By $1.23 EPS - May 11 at 12:27 AM logoAnalysts Anticipate ICU Medical, Incorporated (ICUI) to Announce $0.29 Earnings Per Share - May 10 at 8:44 PM logoICU Medical, Inc. Announces First Quarter 2017 Results - May 10 at 6:25 PM logoICU Medical posts 1Q profit - May 10 at 6:25 PM logoInvestor Network: ICU Medical, Inc. to Host Earnings Call - May 10 at 1:24 PM logoICU Medical, Incorporated (ICUI) Expected to Announce Quarterly Sales of $212.89 Million - May 3 at 2:50 PM logoICU Medical, Incorporated (ICUI) Expected to Announce Earnings of $0.29 Per Share - May 1 at 3:52 PM logoICU Medical, (ICUI) Earns Daily Coverage Optimism Rating of 0.26 - April 29 at 10:47 PM logoLifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical, … - April 28 at 11:51 PM logoICU Medical, Inc. breached its 50 day moving average in a Bullish Manner : ICUI-US : April 28, 2017 - April 28 at 10:05 AM logoICU Medical, (ICUI) Getting Very Favorable News Coverage, Report Finds - April 26 at 9:43 AM logo ICU Medical, Incorporated (ICUI) Receives Consensus Rating of "Buy" from Brokerages - April 24 at 7:56 PM logoICU Medical, (ICUI) Getting Somewhat Critical News Coverage, Analysis Shows - April 23 at 3:37 PM logoICU Medical, (ICUI) Getting Somewhat Positive News Coverage, AlphaOne Reports - April 20 at 11:50 PM logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ICU Medical, Inc. (ICUI) - April 20 at 11:31 AM logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. -- ICUI - April 19 at 5:44 PM logoPfizer is latest to get Justice Department subpoena in intravenous saline investigation - April 19 at 5:44 PM logoPfizer receives subpoenas in U.S. intravenous saline solution probe - April 19 at 11:29 AM logoICU Medical, Inc. – Value Analysis (NASDAQ:ICUI) : April 17, 2017 - April 17 at 5:12 PM logoSomewhat Favorable Press Coverage Somewhat Likely to Impact ICU Medical, (ICUI) Share Price - April 15 at 5:15 PM logoICU Medical, Inc. breached its 50 day moving average in a Bearish Manner : ICUI-US : April 13, 2017 - April 13 at 10:19 AM logoZacks: Analysts Expect ICU Medical, Incorporated (ICUI) to Post $0.29 Earnings Per Share - April 10 at 9:31 AM logoETFs with exposure to ICU Medical, Inc. : April 5, 2017 - April 7 at 10:21 AM logo Brokerages Set $165.67 Target Price for ICU Medical, Incorporated (ICUI) - March 28 at 11:32 AM logoICU Medical, Incorporated (ICUI) Cut to Hold at Zacks Investment Research - March 19 at 12:54 PM logoICU Medical, Incorporated (ICUI) Director Sells $100,188.14 in Stock - March 13 at 10:49 PM logoICU Medical, Incorporated (ICUI) Upgraded at Zacks Investment Research - March 8 at 10:04 PM logoICU Medical, Incorporated (ICUI) Director Joseph R. Saucedo Sells 1,500 Shares - March 8 at 7:01 PM logoICU Medical (ICUI) Presents At The Raymond James 38th Annual Institutional Investors Conference 2017 - March 8 at 6:38 PM logoICU MEDICAL INC/DE Financials - March 7 at 5:35 PM logoICU Medical, Inc. to Present at the 29th Annual ROTH Conference - March 7 at 11:05 AM logoEdited Transcript of ICUI earnings conference call or presentation 1-Mar-17 9:30pm GMT - March 2 at 6:11 PM logoICU Medical's (ICUI) CEO Vivek Jain on Q4 2016 Results - Earnings Call Transcript - March 1 at 10:31 PM logoICU Medical beats 4Q profit forecasts - March 1 at 10:31 PM logo[$$] ICU Medical Outlook Misses Wall Street Targets - March 1 at 10:31 PM logoICU Medical Q4 Profit Tops Estimates; Issues FY17 Guidance - Quick Facts - March 1 at 5:31 PM logoICU Medical, Inc. Announces Fourth Quarter and Fiscal Year 2016 Results - March 1 at 5:31 PM logoICU Medical, Inc. Announces Fourth Quarter and Fiscal Year 2016 Results - March 1 at 5:31 PM logoICU MEDICAL INC/DE Files SEC form 8-K, Financial Statements and Exhibits - March 1 at 5:31 PM logoICU MEDICAL INC/DE Files SEC form 8-K, Financial Statements and Exhibits - March 1 at 5:31 PM logo[$$] Medical Products Company ICU Medical Gives Gloomy Outlook - March 1 at 5:31 PM



ICU Medical, Incorporated (ICUI) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by Staff